Gilles de la Tourette syndrome

Table of Contents

Alternative Names

Tourette syndrome


Treatment

Many patients with Tourette syndrome have very minor symptoms. In this case, they are usually not treated, because the side effects of the medications may be worse than the symptoms of the condition.

Drugs used to treat tics include dopamine blockers, such as fluphenazine, haloperidol, pimozide and risperidone. These medicines can help control or reduce tics, but they have side effects such as movement disorders and cognitive dulling. Antiseizure medications are also used sometimes.

A blood pressure medicine called clonidine has been shown to help control tics. Another drug commonly used is tetrabenazine, but this drug is also linked to movement disorders as well as depression. Many other treatments have been tried with little or no improvement.

Deep brain stimulation (DBS) has given encouraging results both for the main symptoms of Tourette syndrome and for the associated obsessive-compulsive mannerisms.


Support Groups

Tourette Syndrome Association - www.tsa-usa.org


Expectations (prognosis)

Most patients improve in early adulthood. Although 1 in 4 patients may be symptom-free for a few years, only 8% of patients have symptoms completely go away without returning.

People with Tourette syndrome have a normal life expectancy.


Complications

Conditions that may occur in people who have Tourette syndrome include:

  • Anger control issues
  • Attention deficit hyperactivity disorder (ADHD)
  • Impulsive behavior
  • Obsessive-compulsive disorder
  • Poor social skills

These conditions need to be diagnosed and treated.


Calling your health care provider

Make an appointment with your health care provider if you have tics that are severe or persistent, or if they interfere with your daily life.



Review Date: 03/30/2010
Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; Luc Jasmin, MD, PhD, Department of Neurosurgery at Cedars-Sinai Medical Center, Los Angeles, and Department of Anatomy at UCSF, San Francisco, CA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)